Research News

Immune pathway upregulation and lower genomic instability distinguish EBVpositive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS

Primary Epstein-Barr virus (EBV)-positive nodal T/NK-cell lymphoma (PTCL-EBV) is an aggressive and poorly understood disease that occurs mostly in East Asia. In this collaborative study, led by A/Prof Ng Siok Bian and Dr Jason Pitt, the authors and their team characterise PTCL-EBV as an aggressive lymphoma with minimal genomic instability, immune-related gene expression and activation of NFκB along with its associated genes. These findings afford both novel insight into the pathogenesis of this disease and highlight new potential targets for therapeutic development.

Read more: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335103/

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

Spatially Resolved, Tumour Ecosystems in Gastric Cancer Progression

Gastric cancer (GC) has significant global mortality with high heterogeneity. A study of 226 GC samples from 121 patients integrated …

Read More →
Research News

Harnessing TME: Breaking Down EMT Barriers in Cancer Treatment

The tumour microenvironment (TME) plays a pivotal role in cancer progression, metastasis, and therapeutic resistance. Comprised of diverse cells, extracellular …

Read More →
Research News

Unveiling p53’s Role in DNA Protection: New Cancer Insights

Research led by N2CR member Dr. Cheok Chit Fang found that the tumour suppressor protein p53 protects DNA during replication …

Read More →